Literature DB >> 5939

Human enolase isozymes: electrophoretic and biochemical evidence for three loci.

J M Pearce, Y H Edwards, H Harris.   

Abstract

1. Four major enolase isozymes have been identified in human tissues and are referred to as L, M, 'intermediate' and 'fast'. The M isozyme is the major form found in skeletal muscle and heart extracts and the L isozyme the major form found in extracts of liver and most other tissues. The 'intermediate' and 'fast' isozymes are most active in brain but are observed as weak components in most other tissues including heart but are not seen in skeletal muscle. It was observed that during fetal development of heart and skeletal muscle the L form declines in activity while the M form increases in activity. 2. The kinetic properties, heat stabilities and molecular sizes of the main enolase isozymes have been compared. Although the isozymes share many features in common, the 'fast' isozyme is more stable when subjected to heat treatment than either the L or M isozymes. Further, the 'fast' isozyme retains its dimeric structure and activity in the absence of magnesium ions while the L and M isozymes dissociate and lose activity. The 'intermediate' isozyme has properties which are intermediate to those of the L and 'fast' isozymes. 3. The 'intermediate' isozyme can be partially dissociated to equal quantities of L and 'fast' isozymes by storage at room temperature or by freezing and thawing in the presence of 2 M-NaCl. Conversely, mixtures of L with 'fast' and M with 'fast' give rise to an 'intermediate' isozyme after freezing and thawing. 4. Evidence derived from this study has led to the suggestion that three separate gene loci are involved in the determination of human enolase. It is proposed that one of these, ENO1, determines the L isozyme which is the homodimer alphaalpha; another locus, ENO2, determines the 'fast' isozyme which is the homodiner betabeta; and the third locus, ENO3, determines the M isozyme which is the homodimer gammagamma. The 'intermediate' isozyme seen as a strong component in brain and as a weak component in most other tissues is thought to be the heterodimer alphabeta. In heart however it is probably mainly betagamma.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 5939     DOI: 10.1111/j.1469-1809.1976.tb00130.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  9 in total

1.  Nervous system-specific proteins of vertebrates : A search for functions and physiologicla roles.

Authors:  C Zomzely-Neurath; A Keller
Journal:  Neurochem Res       Date:  1977-08       Impact factor: 3.996

Review 2.  Neuronal and glial markers of the central nervous system.

Authors:  C M Regan
Journal:  Experientia       Date:  1988-08-15

3.  A TAT-frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model.

Authors:  Piyush M Vyas; Wendy J Tomamichel; P Melanie Pride; Clifford M Babbey; Qiujuan Wang; Jennifer Mercier; Elizabeth M Martin; R Mark Payne
Journal:  Hum Mol Genet       Date:  2011-11-23       Impact factor: 6.150

4.  Isozyme patterns and protein profiles in neuromuscular disorders.

Authors:  Y H Edwards; T D Tipler; J A Morgan-Hughes; J S Neerunjun; D A Hopkinson
Journal:  J Med Genet       Date:  1982-06       Impact factor: 6.318

5.  Molecular structure of the human muscle-specific enolase gene (ENO3).

Authors:  M Peshavaria; I N Day
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

6.  Methylation patterns in the human muscle-specific enolase gene (ENO3).

Authors:  M Peshavaria; I N Day
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

7.  Selective Usage of Isozymes for Stress Response.

Authors:  Yugang Zhang; Zhewang Lin; Miao Wang; Hening Lin
Journal:  ACS Chem Biol       Date:  2018-11-08       Impact factor: 5.100

8.  Developmental changes in translatable mRNAs for the cerebral enolase isozymes alphaalpha and gammagamma.

Authors:  Y Zeitoun; N Lamandé; A Keller; F Gros; L Legault-Demare
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Targeting Host Glycolysis as a Strategy for Antimalarial Development.

Authors:  Andrew J Jezewski; Yu-Hsi Lin; Julie A Reisz; Rachel Culp-Hill; Yasaman Barekatain; Victoria C Yan; Angelo D'Alessandro; Florian L Muller; Audrey R Odom John
Journal:  Front Cell Infect Microbiol       Date:  2021-09-16       Impact factor: 6.073

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.